Interaction of the innate immune system with positive-strand RNA virus replication organelles

Cytokine and Growth Factor Reviews

Volumn 37, Issue , 2017, Pages 17-27

  Scutigliani, Enzo Maxim ^a   Kikkert, Marjolein ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

+RNA virus; GTPases; Interferon; Replication organelles

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; GUANOSINE TRIPHOSPHATASE; INTERFERON; MICROTUBULE ASSOCIATED PROTEIN 1; PATHOGEN ASSOCIATED MOLECULAR PATTERN; UBIQUITIN; VIRAL PROTEIN; VIRUS RNA;

CELL ORGANELLE; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MEMBRANE STRUCTURE; NONHUMAN; POSITIVE-STRAND RNA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA REPLICATION; RNA VIRUS INFECTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SOCIAL ASPECT; TAXONOMY; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MOUSE; PATHOGENICITY; PHYSIOLOGY; RNA VIRUS; VIROLOGY;

ANIMALS; CYTOKINES; GTP PHOSPHOHYDROLASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERONS; MICE; ORGANELLES; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RNA VIRUSES; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 85022201891     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2017.05.007     Document Type: Short Survey

References (146)

1. Beachboard, D.C., Horner, S.M., Innate immune evasion strategies of DNA and RNA viruses. Curr. Opin. Microbiol. 32 (2016), 113–119, 10.1016/j.mib.2016.05.015.
2. Kawai, T., Akira, S., Innate immune recognition of viral infection. Nat. Immunol. 7 (2006), 131–137, 10.1038/ni1303.
3. Gantier, M.P., Williams, B.R.G., The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev. 18 (2007), 363–371, 10.1016/j.cytogfr.2007.06.016.
4. Brubaker, S.W., Bonham, K.S., Zanoni, I., Kagan, J.C., Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33 (2015), 257–290, 10.1146/annurev-immunol-032414-112240.
5. Errett, J.S., Gale, M., Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity. Virol. Sin. 30 (2015), 163–173, 10.1007/s12250-015-3604-5.
6. van Vliet, A.R., Verfaillie, T., Agostinis, P., New functions of mitochondria associated membranes in cellular signaling. Biochim. Biophys. Acta Mol. Cell Res. 1843 (2014), 2253–2262, 10.1016/j.bbamcr.2014.03.009.
7. Giacomello, M., Pellegrini, L., The coming of age of the mitochondria–ER contact: a matter of thickness. Cell Death Differ. 23 (2016), 1417–1427, 10.1038/cdd.2016.52.
8. Ma, D.Y., Suthar, M.S., Mechanisms of innate immune evasion in re-emerging RNA viruses. Curr. Opin. Virol. 12 (2015), 26–37, 10.1016/j.coviro.2015.02.005.
9. Kai Chan, Y., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing. Nat. Publ. Gr. 14 (2016), 360–373, 10.1038/nrmicro.2016.45.
10. Miller, S., Krijnse-Locker, J., Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 6 (2008), 363–374, 10.1038/nrmicro1890.
11. Den Boon, J.A., Diaz, A., Ahlquist, P., Cytoplasmic viral replication complexes. Cell Host Microbe. 8 (2010), 77–85, 10.1016/j.chom.2010.06.010.
12. Romero-Brey, I., Bartenschlager, R., Membranous replication factories induced by plus-strand RNA viruses. Viruses 6 (2014), 2826–2857, 10.3390/v6072826.
13. Neuman, B.W., Angelini, M.M., Buchmeier, M.J., Does form meet function in the coronavirus replicative organelle?. Trends Microbiol. 22 (2014), 642–647, 10.1016/j.tim.2014.06.003.
14. van der Hoeven, B., Oudshoorn, D., Koster, A.J., Snijder, E.J., Kikkert, M., Bárcena, M., Biogenesis and architecture of arterivirus replication organelles. Virus Res. 220 (2016), 70–90, 10.1016/j.virusres.2016.04.001.
15. Groneberg, D.A., Zhang, L., Welte, T., Zabel, P., Chung, K.F., Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 96 (2003), 845–852 http://www.ncbi.nlm.nih.gov/pubmed/14566040.
16. Aleanizy, F.S., Mohmed, N., Alqahtani, F.Y., El Hadi Mohamed, R.A., Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study. BMC Infect. Dis., 17, 2017, 23, 10.1186/s12879-016-2137-3.
17. Kay, M., Allen, T., Frank, V., Santhana, S., Dye, C., Zika: the origin and spread of a mosquito-borne virus. World Heal. Organ., 2016, 1–18, 10.2471/BLT.16.171082.
18. Shulla, A., Randall, G., (+) RNA virus replication compartments: a safe home for (most) viral replication. Curr. Opin. Microbiol. 32 (2016), 82–88, 10.1016/j.mib.2016.05.003.
19. Paul, D., Bartenschlager, R., Architecture and biogenesis of plus-strand RNA virus replication factories. World J. Virol. May 12 (2013), 32–48, 10.5501/wjv.v2.i2.32.
20. V'kovski, P., Al-Mulla, H., Thiel, V., Neuman, B.W., New insights on the role of paired membrane structures in coronavirus replication. Virus Res. 202 (2015), 33–40, 10.1016/j.virusres.2014.12.021.
21. Welsch, S., Miller, S., Romero-Brey, I., Merz, A., Bleck, C.K.E., Walther, P., Fuller, S.D., Antony, C., Krijnse-Locker, J., Bartenschlager, R., Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe. 5 (2009), 365–375, 10.1016/j.chom.2009.03.007.
22. Grimley, P.M., Berezesky, I.K., Friedman, R.M., Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J. Virol. 2 (1968), 1326–1338.
23. Kujala, P., Ikaheimonen, A., Ehsani, N., Vihinen, H., Auvinen, P., Kaariainen, L., Biogenesis of the Semliki Forest virus RNA replication complex. J. Virol. 75 (2001), 3873–3884, 10.1128/JVI.75.8.3873-3884.2001.
24. Kopek, B.G., Perkins, G., Miller, D.J., Ellisman, M.H., Ahlquist, P., Three-dimensional analysis of a viral RNA replication complex reveals a virus-induced mini-organelle. PLoS Biol., 5, 2007, e220 (07-PLBI-RA-0823 [pii]\r10.1371/journal.pbio.0050220).
25. Froshauer, S., Kartenbeck, J., Helenius, A., Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes. J. Cell Biol. 107 (1988), 2075–2086, 10.1371/journal.pbio.0050220.
26. Junjhon, J., Pennington, J.G., Edwards, T.J., Perera, R., Lanman, J., Kuhn, R.J., Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J. Virol. 88 (2014), 4687–4697, 10.1128/JVI. 00118-14.
27. Romero-Brey, I., Merz, A., Chiramel, A., Lee, J.Y., Chlanda, P., Haselman, U., Santarella-Mellwig, R., Habermann, A., Hoppe, S., Kallis, S., Walther, P., Antony, C., Krijnse-Locker, J., Bartenschlager, R., Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog., 8, 2012, e1003056, 10.1371/journal.ppat.1003056.
28. Beachboard, D.C., Anderson-Daniels, J.M., Denison, M.R., Mutations across murine hepatitis virus nsp4 alter virus fitness and membrane modifications. J. Virol. 89 (2015), 2080–2089, 10.1128/JVI.02776-14.
29. Al-Mulla, H.M.N., Turrell, L., Smith, N.M., Payne, L., Baliji, S., Züst, R., Thiel, V., Baker, S.C., Siddell, S.G., Neuman, B.W., Competitive fitness in coronaviruses is not correlated with size or number of double-membrane vesicles under reduced-temperature growth conditions. MBio, 5, 2014, 10.1128/mBio.01107-13.
30. Knoops, K., Kikkert, M., Van Den Worm, S.H.E., Zevenhoven-Dobbe, J.C., Van Der Meer, Y., Koster, A.J., Mommaas, A.M., Snijder, E.J., SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 6 (2008), 1957–1974, 10.1371/journal.pbio.0060226.
31. Knoops, K., Barcena, M., Limpens, R.W. a. L., Koster, a. J., Mommaas, a. M., Snijder, E.J., Ultrastructural characterization of arterivirus replication structures: reshaping the endoplasmic reticulum to accommodate viral RNA synthesis. J. Virol. 86 (2012), 2474–2487, 10.1128/JVI.06677-11.
32. Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H.E., Moradpour, D., Bienz, K., Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76 (2002), 5974–5984, 10.1128/JVI.76.12.5974.
33. Snijder, E.J., Van Tol, H., Roos, N., Pedersen, K.W., Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex. J. Gen. Virol. 82 (2001), 985–994, 10.1099/vir.0.17499-0.
34. Angelini, M., Akhlaghpour, M., Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 Induce double-membrane vesicles. MBio 4 (2013), 1–10, 10.1128/mBio.00524-13 Editor.
35. Mcnab, F., Mayer-barber, K., Sher, A., Wack, A., Garra, A.O., Type I interferons in infectious disease. Nat. Publ. Gr. 15 (2015), 87–103, 10.1038/nri3787.
36. Darwich, L., Coma, G., Peña, R., Bellido, R., Blanco, E.J.J., Este, J.A., Borras, F.E., Clotet, B., Ruiz, L., Rosell, A., Andreo, F., Parkhouse, R.M.E., Bofill, M., Secretion of interferon-(by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 126 (2009), 386–393, 10.1111/j.1365-2567.2008.02905.x.
37. Schoenborn, J.R., Wilson, C.B., Regulation of interferon-γ during innate and adaptive immune responses. Adv. Immunol. 96 (2007), 41–101, 10.1016/S0065-2776(07)96002-2.
38. Iversen, M.B., Paludan, S.R., Mechanisms of type III interferon expression. J. Interferon Cytokine Res. 30 (2010), 573–578, 10.1089/jir.2010.0063.
39. Sommereyns, C., Paul, S., Staeheli, P., Michiels, T., IFN-lambda (IFN-??) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog., 4, 2008, 10.1371/journal.ppat.1000017.
40. Ströher, U., DiCaro, A., Li, Y., Strong, J.E., Aoki, F., Plummer, F., Jones, S.M., Feldmann, H., Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. J. Infect. Dis. 189 (2004), 1164–1167, 10.1086/382597.
41. Sainz, B., Mossel, E.C., Peters, C.J., Garry, R.F., Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329 (2004), 11–17, 10.1016/j.virol.2004.08.011.
42. Barnard, D.L., Day, C.W., Bailey, K., Heiner, M., Montgomery, R., Lauridsen, L., Chan, P.K.S., Sidwell, R.W., Evaluation of immunomodulators, interferons and known in vitro SARS-CoV inhibitors for inhibition of SARS-CoV replication in BALB/c mice, Antivir. Chem. Chemother. 17 (2006), 275–284.
43. Kumaki, Y., Ennis, J., Rahbar, R., Turner, J.D., Wandersee, M.K., Smith, A.J., Bailey, K.W., Vest, Z.G., Madsen, J.R., Li, J.K.K., Barnard, D.L., Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Res. 89 (2011), 75–82, 10.1016/j.antiviral.2010.11.007.
44. Loo, Y.M., Gale, M., Immune signaling by RIG-I-like receptors. Immunity 34 (2011), 680–692, 10.1016/j.immuni.2011.05.003.
45. Sparrer, K.M.J., Gack, M.U., Intracellular detection of viral nucleic acids. Curr. Opin. Microbiol. 26 (2015), 1–9, 10.1016/j.mib.2015.03.001.
46. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi, O., Akira, S., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005), 981–988, 10.1038/ni1243.
47. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., Tschopp, J., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005), 1167–1172, 10.1038/nature04193.
48. Seth, R.B., Sun, L., Ea, C.K., Chen, Z.J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-??B and IRF3. Cell 122 (2005), 669–682, 10.1016/j.cell.2005.08.012.
49. Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z., Shu, H.B., VISA is an adapter protein required for virus-triggered IFN-?.?. signaling. Mol. Cell. 19 (2005), 727–740, 10.1016/j.molcel.2005.08.014.
50. West, A.P., Shadel, G.S., Ghosh, S., Mitochondria in innate immune responses. Nat. Rev. Immunol. 11 (2011), 389–402, 10.1038/nri2975.
51. Lester, S.N., Li, K., Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426 (2014), 1246–1264, 10.1016/j.jmb.2013.11.024.
52. Zhang, Q., Yoo, D., Immune evasion of porcine enteric coronaviruses and viral modulation of antiviral innate signaling. Virus Res., 2016, 10.1016/j.virusres.2016.05.015.
53. Frieman, M.B., Chen, J., Morrison, T.E., Whitmore, A., Funkhouser, W., Ward, J.M., Lamirande, E.W., Roberts, A., Heise, M., Subbarao, K., Baric, R.S., SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog., 6, 2010, e1000849, 10.1371/journal.ppat.1000849.
54. Schoggins, J.W., Rice, C.M., Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1 (2011), 519–525, 10.1016/j.coviro.2011.10.008.
55. Sadler, A.J., Williams, B.R.G., Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8 (2008), 559–568, 10.1038/nri2314.
56. Borden, E.C., Williams, B.R., Interferon-stimulated genes and their protein products: what and how?. J. Interferon Cytokine Res. 31 (2011), 1–4, 10.1089/jir.2010.0129.
57. Sun, W., Li, Y., Chen, L., Chen, H., You, F., Zhou, X., Zhou, Y., Zhai, Z., Chen, D., Jiang, Z., ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 8653–8658 (0900850106 [pii]\r10.1073/pnas.0900850106).
58. Horner, S.M., Liu, H.M., Park, H.S., Briley, J., Gale, M., Mitochondrial-associated endoplasmic reticulum membranes {(MAM)} form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. {U.S.A.}. 108 (2011), 14590–14595, 10.1073/pnas.1110133108.
59. Dixit, E., Boulant, S., Zhang, Y., Lee, A.S.Y., Odendall, C., Shum, B., Hacohen, N., Chen, Z.J., Whelan, S.P., Fransen, M., Nibert, M.L., Superti-Furga, G., Kagan, J.C., Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141 (2010), 668–681, 10.1016/j.cell.2010.04.018.
60. Costello, J.L., Castro, I.G., Hacker, C., Schrader, T.A., Metz, J., Zeuschner, D., Azadi, A.S., Godinho, L.F., Costina, V., Findeisen, P., Manner, A., Islinger, M., Schrader, M., ACBD5 and VAPB mediate membrane associations between peroxisomes and the ER. J. Cell Biol. 216 (2017), 1–12, 10.1083/jcb.201607055.
61. Strzyz, P., Organelle dynamics: connections, connections, connections. Nat Rev. Mol. Cell Biol., 18, 2017, 139, 10.1038/nrm.2017.14.
62. Hua, R., Coyaud, D.É., Freeman, S., Di Pietro, E., Wang, Y., Vissa, A., Yip, C.M., Fairn, G.D., Braverman, N., Brumell, J.H., Trimble, W.S., Raught, B., Kim, P.K., VAPs and ACBD5 tether peroxisomes to the ER for peroxisome maintenance and lipid homeostasis., Cheng. J. Cell Biol. 216 (2017), 1–11, 10.1083/jcb.201608128.
63. Onomoto, K., Yoneyama, M., Fung, G., Kato, H., Fujita, T., Antiviral innate immunity and stress granule responses. Trends Immunol. 35 (2014), 420–428, 10.1016/j.it.2014.07.006.
64. Ruggieri, A., Dazert, E., Metz, P., Hofmann, S., Bergeest, J.-P., Mazur, J., Bankhead, P., Hiet, M.-S., Kallis, S., Alvisi, G., Samuel, C.E., Lohmann, V., Kaderali, L., Rohr, K., Frese, M., Stoecklin, G., Bartenschlager, R., Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. Cell Host Microbe 12 (2012), 71–85, 10.1016/j.chom.2012.05.013.
65. Onomoto, K., Jogi, M., Yoo, J.S., Narita, R., Morimoto, S., Takemura, A., Sambhara, S., Kawaguchi, A., Osari, S., Nagata, K., Matsumiya, T., Namiki, H., Yoneyama, M., Fujita, T., Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One, 7, 2012, 10.1371/journal.pone.0043031.
66. Ng, C.S., Jogi, M., Yoo, J.-S., Onomoto, K., Koike, S., Iwasaki, T., Yoneyama, M., Kato, H., Fujita, T., Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J. Virol. 87 (2013), 9511–9522, 10.1128/JVI.03248-12.
67. Langereis, M.A., Feng, Q., van Kuppeveld, F.J., MDA5 localizes to stress granules, but this localization is not required for the induction of type I interferon. J. Virol. 87 (2013), 6314–6325, 10.1128/JVI.03213-12.
68. Uchil, P.D., Satchidanandam, V., Characterization of RNA synthesis, replication mechanism, and in vitro RNA-dependent RNA polymerase activity of Japanese encephalitis virus. Virology 307 (2003), 358–371 (S0042682202001307 [pii]).
69. Uchil, P.D., Satchidanandam, V., Architecture of the flaviviral replication complex: protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J. Biol. Chem. 278 (2003), 24388–24398, 10.1074/jbc.M301717200.
70. Van Hemert, M.J., Van Den Worm, S.H.E., Knoops, K., Mommaas, A.M., Gorbalenya, A.E., Snijder, E.J., SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog., 4, 2008, 10.1371/journal.ppat.1000054.
71. Van Hemert, M.J., De Wilde, A.H., Gorbalenya, A.E., Snijder, E.J., The in vitro RNA synthesizing activity of the isolated arterivirus replication/transcription complex is dependent on a host factor. J. Biol. Chem. 283 (2008), 16525–16536, 10.1074/jbc.M708136200.
72. Uchida, L., Espada-Murao, L.A., Takamatsu, Y., Okamoto, K., Hayasaka, D., Yu, F., Nabeshima, T., Buerano, C.C., Morita, K., The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response. Sci. Rep., 4, 2014, 7395, 10.1038/srep07395.
73. Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.-Y., Schneller, S., Zust, R., Dong, H., Thiel, V., Sen, G.C., Fensterl, V., Klimstra, W.B., Pierson, T.C., Buller, R.M., Gale, M., Shi, P.-Y., Diamond, M.S., 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 (2010), 452–456, 10.1038/nature09489.
74. Menachery, V.D., Yount, B.L., Josset, L., Gralinski, L.E., Scobey, T., Agnihothram, S., Katze, M.G., Baric, R.S., Attenuation and restoration of SARS-CoV mutant lacking 2′O methyltransferase activity. J. Virol. 88 (2014), 4251–4264, 10.1128/JVI.03571-13.
75. Li, S.-H., Dong, H., Li, X.-F., Xie, X., Zhao, H., Deng, Y.-Q., Wang, X.-Y., Ye, Q., Zhu, S.-Y., Wang, H.-J., Zhang, B., Leng, Q.-B., Zuest, R., Qin, E.-D., Qin, C.-F., Shi, P.-Y., Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation. J. Virol. 87 (2013), 5812–5819, 10.1128/JVI.02806-12.
76. Kindler, E., Gil-Cruz, C., Spanier, J., Li, Y., Wilhelm, J., Rabouw, H.H., Züst, R., Hwang, M., V'kovski, P., Stalder, H., Marti, S., Habjan, M., Cervantes-Barragan, L., Elliot, R., Karl, N., Gaughan, C., van Kuppeveld, F.J.M., Silverman, R.H., Keller, M., Ludewig, B., Bergmann, C.C., Ziebuhr, J., Weiss, S.R., Kalinke, U., Thiel, V., Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog., 13, 2017, e1006195, 10.1371/journal.ppat.1006195.
77. Li, X.-D., Sun, L., Seth, R.B., Pineda, G., Chen, Z.J., Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 17717–17722, 10.1073/pnas.0508531102.
78. Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S.M., Gale, M., Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003), 1145–1148, 10.1126/science.1082604.
79. Foy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C.L., Wang, C., Fish, P.M., Yoneyama, M., Fujita, T., Lemon, S.M., Gale, M., Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 2986–2991, 10.1073/pnas.0408707102.
80. Loo, Y.-M., Owen, D.M., Li, K., Erickson, A.K., Johnson, C.L., Fish, P.M., Carney, D.S., Wang, T., Ishida, H., Yoneyama, M., Fujita, T., Saito, T., Lee, W.M., Hagedorn, C.H., Lau, D.T.-Y., Weinman, S.A., Lemon, S.M., Gale, M., Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 6001–6006, 10.1073/pnas.0601523103.
81. Miller, S., Kastner, S., Krijnse-Locker, J., Bühler, S., Bartenschlager, R., The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282 (2007), 8873–8882, 10.1074/jbc.M609919200.
82. He, Z., Zhu, X., Wen, W., Yuan, J., Hu, Y., Chen, J., An, S., Dong, X., Lin, C., Yu, J., Wu, J., Yang, Y., Cai, J., Li, J., Li, M., Dengue virus subverts host innate immunity by targeting adaptor protein MAVS. J. Virol. 90 (2016), 7219–7230, 10.1128/JVI.00221-16.
83. Rodriguez-Madoz, J.R., Belicha-Villanueva, A., Bernal-Rubio, D., Ashour, J., Ayllon, J., Fernandez-Sesma, A., Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J. Virol. 84 (2010), 9760–9774, 10.1128/JVI.01051-10.
84. Yu, C.Y., Chang, T.H., Liang, J.J., Chiang, R.L., Lee, Y.L., Liao, C.L., Lin, Y.L., Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog., 8, 2012, 10.1371/journal.ppat.1002780.
85. Aguirre, S., Maestre, A.M., Pagni, S., Patel, J.R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R.S., Simon, V., Rodriguez-Madoz, J.R., Mulder, L.C.F., Barber, G.N., Fernandez-Sesma, A., DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog., 8, 2012, 10.1371/journal.ppat.1002934.
86. Ding, Q., Cao, X., Lu, J., Huang, B., Liu, Y.J., Kato, N., Shu, H.B., Zhong, J., Hepatitis C virus NS4 B blocks the interaction of STING and TBK1 to evade host innate immunity. J. Hepatol. 59 (2013), 52–58, 10.1016/j.jhep.2013.03.019.
87. Nitta, S., Sakamoto, N., Nakagawa, M., Kakinuma, S., Mishima, K., Kusano-Kitazume, A., Kiyohashi, K., Murakawa, M., Nishimura-Sakurai, Y., Azuma, S., Tasaka-Fujita, M., Asahina, Y., Yoneyama, M., Fujita, T., Watanabe, M., Hepatitis C virus NS4 B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology 57 (2013), 46–58, 10.1002/hep.26017.
88. Mielech, A.M., Chen, Y., Mesecar, A.D., Baker, S.C., Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities. Virus Res. 194 (2014), 184–190, 10.1016/j.virusres.2014.01.025.
89. van Kasteren, P.B., a Bailey-Elkin, B., James, T.W., Ninaber, D.K., Beugeling, C., Khajehpour, M., Snijder, E.J., Mark, B.L., Kikkert, M., Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E838–E847, 10.1073/pnas.1218464110.
90. Bailey-Elkin, B.A., Knaap, R.C.M., Johnson, G.G., Dalebout, T.J., Ninaber, D.K., Van Kasteren, P.B., Bredenbeek, P.J., Snijder, E.J., Kikkert, M., Mark, B.L., Crystal structure of the middle east respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J. Biol. Chem. 289 (2014), 34667–34682, 10.1074/jbc.M114.609644.
91. Angleró-Rodríguez, Y.I., Pantoja, P., Sariol, C.A., Dengue virus subverts the interferon induction pathway via NS2B/3 protease-I(B kinase (interaction. Clin. Vaccine Immunol. 21 (2014), 29–38, 10.1128/CVI.00500-13.
92. Fang, X., Gao, J., Zheng, H., Li, B., Kong, L., Zhang, Y., Wang, W., Zeng, Y., Ye, L., The membrane protein of SARS-CoV suppresses NF-kappaB activation. J. Med. Virol. 79 (2007), 1431–1439, 10.1002/jmv.20953.
93. Kopecky-Bromberg, S.a., Martínez-Sobrido, L., Frieman, M., Baric, R.a., Palese, P., Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81 (2007), 548–557, 10.1128/JVI.01782-06.
94. Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z., Tan, W., The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. 4 (2013), 951–961, 10.1007/s13238-013-3096-8.
95. Mansfield, K.L., Johnson, N., Cosby, S.L., Solomon, T., Fooks, A.R., Transcriptional upregulation of SOCS 1 and suppressors of cytokine signaling 3 mRNA in the absence of suppressors of cytokine signaling 2 mRNA after infection with West Nile virus or tick-borne encephalitis virus. Vector Borne Zoonotic Dis. 10 (2010), 649–653, 10.1089/vbz.2009.0259.
96. Patil, D.R., Hundekar, S.L., Arankalle, V.A., Expression profile of immune response genes during acute myopathy induced by chikungunya virus in a mouse model. Microbes Infect. 14 (2012), 457–469, 10.1016/j.micinf.2011.12.008.
97. Kundu, K., Dutta, K., Nazmi, A., Basu, A., Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts’ innate immune response. Cell. Immunol. 285 (2013), 100–110, 10.1016/j.cellimm.2013.09.005.
98. Guo, J.-T., Hayashi, J., Seeger, C., West Nile virus inhibits the signal transduction pathway of alpha interferon. J. Virol. 79 (2005), 1343–1350, 10.1128/JVI.79.3.1343-1350.2005.
99. Lin, R.J., Chang, B.L., Yu, H.P., Liao, C.L., Lin, Y.L., Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J. Virol. 80 (2006), 5908–5918, 10.1128/JVI.02714-05.
100. Wathelet, M.G., Orr, M., Frieman, M.B., Baric, R.S., Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 81 (2007), 11620–11633, 10.1128/JVI.00702-07.
101. Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S.A., Palese, P., Baric, R.S., Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 81 (2007), 9812–9824, 10.1128/JVI.01012-07.
102. Li, S.W., Lai, C.C., Ping, J.F., Tsai, F.J., Wan, L., Lin, Y.J., Kung, S.H., Lin, C.W., Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways. J. Gen. Virol. 92 (2011), 1127–1140, 10.1099/vir.0.028936-0.
103. White, J.P., Cardenas, A.M., Marissen, W.E., Lloyd, R.E., Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe. 2 (2007), 295–305, 10.1016/j.chom.2007.08.006.
104. Garaigorta, U., Heim, M.H., Boyd, B., Wieland, S., Chisari, F.V., Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress. J. Virol. 86 (2012), 11043–11056, 10.1128/JVI.07101-11.
105. Katoh, H., Okamoto, T., Fukuhara, T., Kambara, H., Morita, E., Mori, Y., Kamitani, W., Matsuura, Y., Japanese encephalitis virus core protein inhibits stress granule formation through an interaction with Caprin-1 and facilitates viral propagation. J. Virol. 87 (2013), 489–502, 10.1128/JVI.02186-12.
106. Emara, M.M., Brinton, M.A., Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 9041–9046, 10.1073/pnas.0703348104.
107. Ruggieri, A., Dazert, E., Metz, P., Hofmann, S., Bergeest, J.-P., Mazur, J., Bankhead, P., Hiet, M.-S., Kallis, S., Alvisi, G., Samuel, C.E., Lohmann, V., Kaderali, L., Rohr, K., Frese, M., Stoecklin, G., Bartenschlager, R., Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. Cell Host Microbe. 12 (2012), 71–85, 10.1016/j.chom.2012.05.013.
108. Scholte, F.E.M., Tas, A., Albulescu, I.C., Žusinaite, E., Merits, A., Snijder, E.J., van Hemert, M.J., Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication. J. Virol. 89 (2015), 4457–4469, 10.1128/JVI.03612-14.
109. Rabouw, H.H., Langereis, M.A., Knaap, R.C.M., Dalebout, T.J., Canton, J., Sola, I., Enjuanes, L., Bredenbeek, P.J., Kikkert, M., de Groot, R.J., van Kuppeveld, F.J.M., Middle east respiratory Coronavirus accessory protein 4a inhibits PKR-Mediated antiviral stress responses. PLoS Pathog. 12 (2016), 1–26, 10.1371/journal.ppat.1005982.
110. Chatel-Chaix, M., Romero-Brey, S., Bender, C.J., Neufeldt, W., Fischl, P., Scaturro, N., Schieber, Y., Schwab, B., Fischer, A., Bartenschlager, R., Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe., 2016, 1–15, 10.1016/j.chom.2016.07.008.
111. Neufeldt, C.J., Joyce, M.A., Van Buuren, N., Levin, A., Kirkegaard, K., Gale, M., Tyrrell, D.L.J., Wozniak, R.W., The hepatitis C virus-induced membranous web and associated nuclear transport machinery limit access of pattern recognition receptors to viral replication sites. PLoS Pathog., 12, 2016, 10.1371/journal.ppat.1005428.
112. Anggakusuma, I., Romero-Brey, C., Berger, C.C., Colpitts, T., Boldanova, M., Engelmann, D., Todt, P.M., Perin, P., Behrendt, F.W.R., Vondran, S., Xu, C., Goffinet, L.M., Schang, M.H., Heim, R., Bartenschlager, T., Pietschmann Steinmann, E., Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation. Hepatology 62 (2015), 702–714, 10.1002/hep.27913.
113. Helbig, K.J., Eyre, N.S., Yip, E., Narayana, S., Li, K., Fiches, G., Mccartney, E.M., Jangra, R.K., Lemon, S.M., Beard, M.R., The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 54 (2011), 1506–1517, 10.1002/hep.24542.
114. Oudshoorn, D., Van der Hoeven, B., Limpens, R.W.A.L., Beugeling, C., Snijder, E.J., Bárcena, M., Kikkert, M., Antiviral innate immune response interferes with the formation of replication-associated membrane structures induced by a +RNA virus. MBio 7 (2016), 1–11, 10.1128/mBio.01991-16.
115. Coers, J., Self and non-self discrimination of intracellular membranes by the innate immune system. PLoS Pathog. 9 (2013), 10–13, 10.1371/journal.ppat.1003538.
116. Pilla-Moffett, D., Barber, M.F., Taylor, G.A., Coers, J., Interferon-inducible GTPases in host resistance, inflammation and disease. J. Mol. Biol. 428 (2016), 3495–3513, 10.1016/j.jmb.2016.04.032.
117. Kim, B.H., Shenoy, A.R., Kumar, P., Bradfield, C.J., MacMicking, J.D., IFN-inducible GTPases in host cell defense. Cell Host Microbe. 12 (2012), 432–444, 10.1016/j.chom.2012.09.007.
118. Haldar, A.K., Saka, H.A., Piro, A.S., Da Dunn, J., Henry, S.C., Taylor, G.A., Frickel, E.M., Valdivia, R.H., Coers, J., IRG and GBP host resistance factors target aberrant, non-self vacuoles characterized by the missing of self IRGM proteins. PLoS Pathog., 9, 2013, 10.1371/journal.ppat.1003414.
119. Coers, J., Bernstein-Hanley, I., Grotsky, D., Parvanova, I., Howard, J.C., a Taylor, G., Dietrich, W.F., Starnbach, M.N., Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J. Immunol. 180 (2008), 6237–6245 (180/9/6237 [pii]).
120. da Fonseca Ferreira-da-Silva, M., Springer-Frauenhoff, H.M., Bohne, W., Howard, J.C., Identification of the microsporidian encephalitozoon cuniculi as a new target of the IFN-γ inducible IRG resistance system. PLoS Pathog., 10, 2014, 10.1371/journal.ppat.1004449.
121. Howard, J.C., Hunn, J.P., Steinfeldt, T., The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii. Curr. Opin. Microbiol. 14 (2011), 414–421, 10.1016/j.mib.2011.07.002.
122. Zhao, Z., Fux, B., Goodwin, M., Dunay, I.R., Strong, D., Miller, B.C., Cadwell, K., Delgado, M.A., Ponpuak, M., Green, K.G., Schmidt, R.E., Mizushima, N., Deretic, V., Sibley, L.D., Virgin, H.W., Autophagosome-independent essential function for the autophagy protein atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe. 4 (2008), 458–469, 10.1016/j.chom.2008.10.003.
123. Choi, J., Park, S., Biering, S.B., Selleck, E., Liu, C.Y., Zhang, X., Fujita, N., Saitoh, T., Akira, S., Yoshimori, T., Sibley, L.D., Hwang, S., Virgin, H.W., The parasitophorous vacuole membrane of toxoplasma gondii is targeted for disruption by ubiquitin-like conjugation systems of autophagy. Immunity 40 (2014), 924–935, 10.1016/j.immuni.2014.05.006.
124. Choi, J., Biering, S.B., Hwang, S., Quo vadis?. Interferon-inducible GTPases go to their target membranes via the LC3-conjugation system of autophagy. Small GTPases 0 (2016), 1–9, 10.1080/21541248.2016.1213090.
125. Park, S., Choi, J., Biering, S.B., Dominici, E., Williams, L.E., Hwang, S., Targeting by AutophaGy proteins (TAG): Targeting of IFNG-inducible GTPases to membranes by the LC3 conjugation system of autophagy. Autophagy 12 (2016), 1153–1167, 10.1080/15548627.2016.1178447.
126. Kimura, S., Noda, T., Yoshimori, T., Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3 (2007), 452–460 (4451 [pii]).
127. Pimentel-Muiños, F.X., Boada-Romero, E., Selective autophagy against membranous compartments: canonical and unconventional purposes and mechanisms. Autophagy 10 (2014), 397–407, 10.4161/auto.27244.
128. Bestebroer, J., V'kovski, P., Mauthe, M., Reggiori, F., Hidden behind autophagy: the unconventional roles of ATG proteins. Traffic 14 (2013), 1029–1041, 10.1111/tra.12091.
129. Welchman, R.L., Gordon, C., Mayer, R.J., Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 6 (2005), 599–609, 10.1038/nrm1700.
130. Haldar, A.K., Foltz, C., Finethy, R., Piro, A.S., Feeley, E.M., Pilla-Moffett, D.M., Komatsu, M., Frickel, E.-M., Coers, J., Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins. Proc. Natl. Acad. Sci. 112 (2015), E5628–E5637, 10.1073/pnas.1515966112.
131. Zhao, Y., Ferguson, D.J.P., Wilson, D., Howard, J.C., Sibley, L.D., Yap, G.S., Virulent toxoplasma gondii evade immunity-related GTPase (IRG)-Mediated parasite vacuole disruption within primed macrophages. J. Immunol. 182 (2010), 3775–3781, 10.4049/jimmunol.0804190.Virulent.
132. Khaminets, A., Hunn, J.P., Könen-Waisman, S., Zhao, Y.O., Preukschat, D., Coers, J., Boyle, J.P., Ong, Y.C., Boothroyd, J.C., Reichmann, G., Howard, J.C., Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell. Microbiol. 12 (2010), 939–961, 10.1111/j.1462-5822.2010.01443.x.
133. Monastyrska, I., Ulasli, M., Rottier, P.J.M., Guan, J.L., Reggiori, F., De Haan, C.A.M., An autophagy-independent role for LC3 in equine arteritis virus replication. Autophagy 9 (2013), 164–174, 10.4161/auto.22743.
134. Reggiori, F., Monastyrska, I., Verheije, M.H., Calì, T., Ulasli, M., Bianchi, S., Bernasconi, R., De Haan, C.A.M., Molinari, M., Coronaviruses hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe. 7 (2010), 500–508, 10.1016/j.chom.2010.05.013.
135. Hwang, S., Maloney, N.S., Bruinsma, M.W., Goel, G., Duan, E., Zhang, L., Shrestha, B., Diamond, M.S., Dani, A., Sosnovtsev, S.V., Green, K.Y., Lopez-Otin, C., Xavier, R.J., Thackray, L.B., Virgin, H.W., Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe. 11 (2012), 397–409, 10.1016/j.chom.2012.03.002.
136. Fujita, N., Itoh, T., Omori, H., Fukuda, M., Noda, T., Yoshimori, T., The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 19 (2008), 2092–2100, 10.1091/mbc.E07-12-1257\rE07-12-1257[pii].
137. Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., Yoshimori, T., LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 117 (2004), 2805–2812, 10.1242/jcs.01131\r117/13/2805 (pii).
138. Tanida, I., Ueno, T., Kominami, E., Human light chain 3/MAP1LC3 B Is cleaved at its carboxyl-terminal Met 121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J. Biol. Chem. 279 (2004), 47704–47710, 10.1074/jbc.M407016200.
139. Tanida, I., Sou, Y.S., Ezaki, J., Minematsu-Ikeguchi, N., Ueno, T., Kominami, E., HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates. J. Biol. Chem. 279 (2004), 36268–36276, 10.1074/jbc.M401461200.
140. Martinez-Lopez, N., Athonvarangkul, D., Mishall, P., Sahu, S., Singh, R., Autophagy proteins regulate ERK phosphorylation. Nat. Commun., 4, 2013, 2799, 10.1038/ncomms3799.
141. Yang, Z., Wilkie-Grantham, R.P., Yanagi, T., Shu, C.W., Matsuzawa, S.I., Reed, J.C., ATG4B (Autophagin-1) phosphorylation modulates autophagy. J. Biol. Chem. 290 (2015), 26549–26561, 10.1074/jbc.M115.658088.
142. Mitchell, P.S., Young, J.M., Emerman, M., Malik, H.S., Evolutionary analyses suggest a function of MxB immunity proteins beyond lentivirus restriction. PLoS Pathog., 11, 2015, 10.1371/journal.ppat.1005304.
143. Kane, M., Yadav, S.S., Bitzegeio, J., Kutluay, S.B., Zang, T., Wilson, S.J., Schoggins, J.W., Rice, C.M., Yamashita, M., Hatziioannou, T., Bieniasz, P.D., MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502 (2013), 563–566, 10.1038/nature12653.
144. Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C.C., Schaller, T., Hué, S., Barclay, W.S., Schulz, R., Malim, M.H., Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502 (2013), 559–562, 10.1038/nature12542.
145. Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., Cen, S., Guo, F., Liang, C., The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe. 14 (2013), 398–410, 10.1016/j.chom.2013.08.015.
146. Ahlquist, P., Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses. Nat. Rev. Microbiol. 4 (2006), 371–382, 10.1038/nrmicro1389.